Lyons_LM Profile Banner
Lisa lyons Profile
Lisa lyons

@Lyons_LM

Followers
290
Following
4K
Media
3
Statuses
87

Haematology ANP with an interest in how frailty impacts people living with blood cancer

Joined August 2021
Don't wanna be here? Send us removal request.
@CACancerJournal
CA: A Cancer Journal for Clinicians
10 days
Geriatric oncology has made great strides in improving outcomes for older adults with cancer. In a 2024 #OpenAccess review, @rochgerionc et al discuss the why, what, and how of geriatric assessment for clinicians. Revisit it here: https://t.co/Bl6QXM5Qoy @OncoAlert #GeriOnc
0
14
26
@BMJOncology
BMJ Oncology
18 days
Loneliness and social isolation can have significant psychological effects on patients with cancer -- and even lead to increased mortality. https://t.co/UvxTiOmtHV
1
2
7
@richardbuka
Richard Buka 💙
5 months
We need an RCT to work out whether there is any benefit at all to venesection or whether we can simply see once in clinic and discharge the vast majority of patients who do not have JAK2 mutation. Well done to @PipNicolson and supported by @HaemSTAR_UK.
0
1
4
@ChrisQuinn64
Chris Quinn 💫
5 months
#Leadership that connects people and helps a community grow together…
4
49
188
@MyelomaEurope
Myeloma Patients Europe
6 months
💬 #Treatment challenges from a #patient perspective include: • Burden on daily life • Emotional stress (toll of chronic therapy) • Complex treatment regimens • Lack of coordinated care #EHA2025 #myeloma
0
2
3
@annmcbrien_
Ann McBrien
6 months
Brilliant to see trial 👇🏻published with such great results & publicity. Prof @vic_coyle from Northern Ireland is the UK lead for this trial, an oncologist, academic & lead for @nicancertrials ECMC. She works tirelessly to improve outcomes for patients & an all-round super person.
@oncology_bg
Bishal Gyawali, MD, PhD, FASCO
6 months
The most practice changing trial from #ASCO25 is now live on @NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.
1
11
32
@Lyndseydunn7
Lyndsey Dunn ( Also on Blue Sky)
7 months
Nurses everywhere today we celebrate you and our amazing profession I'm so thankful that I'm part of this amazing profession & continuing to learn everyday 💯🥰... Happy International Nurses Day to all the amazing nurses who continue to turn up and for their patients everyday
@GeriSoc
British Geriatrics Society
7 months
To mark #NursesDay today, @Lyndseydunn7 and BGS nurse representatives from all 4 UK nations have been gathering reflections and career journeys from colleagues which highlight the diverse contributions of nursing and the vast opportunities available. https://t.co/oSlDXGMzev
0
3
12
@KirstyCrozier
Kirsty Crozier💙
7 months
Understanding the emotional labour costs in the haematology workforce #BSH2025 @BritSocHaem @alisonleary1
0
6
11
@BritSocHaem
BSH - Haematology
8 months
Addressing wellbeing in haematology is not only crucial for staff retention but also for ensuring high-quality patient care
0
5
9
@RCNi_Sprinks
Jennifer Sprinks
8 months
Role of the clinical nurse specialist in impacting quality of care: a qualitative exploratory interview study utilising complexity theory
Tweet card summary image
journals.rcni.com
Role of the clinical nurse specialist in impacting quality of care: a qualitative exploratory interview study utilising complexity theory
0
19
20
@VincentRK
Vincent Rajkumar
8 months
We stop all premeds (steroids, antihistamines, and acetaminophen) after cycle 1 for both IV and SQ dara. If someone has had reactions with even the last dose of cycle 1, then for that patient, these may be continued, but otherwise no.   Here is a paper on our experience.
Tweet card summary image
ascopubs.org
PURPOSEDaratumumab is an anti-CD38 monoclonal antibody used to treat multiple myeloma and light chain amyloidosis. Because daratumumab may cause reactions after intravenous or subcutaneous (SC)...
@Lyons_LM
Lisa lyons
9 months
For those reducing dexamethasone in patients on DRd or Dara monotherapy, do you stop Dex pre-meds before Daratumumab? Have you seen increased infusion reactions? And for DRd, what thromboprophylaxis do you use if Dex is reduced/stopped? #myeloma #downwithdex
4
34
100
@HAINurses_AHPs
Haematology Association of Ireland Nurses & AHPs
9 months
📢 Nurse/AHP Group Spring Study Day 2025 🗓Friday 11th April 📌 Hyatt Centric, D08 W3X7 REGISTER HERE: https://t.co/3NZCNkfd8c Free to attend + agenda attached! We hope to see you soon!
0
5
12
@nhs_voices
NHS Voices
9 months
✨ Meet Professor Alison Leary @alisonleary1 – Winner of Exemplary Leadership and Mentorship ✨ She has made outstanding contributions to healthcare workforce modelling and patient safety. #InternationalWomensDay #InternationalWomensDay2025 #NHS_Voices
13
26
97
@BreastDocUK
Richard Simcock
9 months
Nicola Ranger from @theRCN on #safestaffing: There is legislation that a dog walker can have no more than 6 dogs Yet no legal limit on how many sick people a nurse can be asked to manage
3
16
40
@Lyons_LM
Lisa lyons
9 months
For those reducing dexamethasone in patients on DRd or Dara monotherapy, do you stop Dex pre-meds before Daratumumab? Have you seen increased infusion reactions? And for DRd, what thromboprophylaxis do you use if Dex is reduced/stopped? #myeloma #downwithdex
1
1
4
@JaneEBall
Prof Jane Ball (FRCN)💙
11 months
NEW PAPER: Nursing is NOT a set of tasks. Our theoretical proposition elucidates the complexity of daily work. Understanding the complexity and interconnectednes of nursing care (and expertise needed) reveals the risks of staffing by task allocation
8
87
199
@squinteratn
Squinter
11 months
1/7 Sometimes I don't understand why people who come to work and live among us stay here when so many try to drive them away. I want to tell you how humanity and kindness and love are not learned – and can't be learned. I want to tell you about my brother Billy and his friend...
130
393
2K
@RahulBanerjeeMD
Rahul Banerjee, MD, FACP
11 months
And thanks @jmikhaelmd #susieharding for kind commentary about our SWOG dexamethasone analysis, now published in @BloodJournal: #downwithdex now has its first official citation in myeloma #MMsm 👏 Excited to see so much prospective research here now! https://t.co/bGf8dKOTBj
@RahulBanerjeeMD
Rahul Banerjee, MD, FACP
1 year
Grateful to @BloodJournal, co-authors, and @SWOG for making this #downwithdex piece possible! Dex 40mg weekly in #MMsm induction: 1️⃣ Not practical even for trial-enrolled patients 2️⃣ Does not improve PFS vs ⬇️ dex Twitter 🧵 once I’m back from #IMS24! https://t.co/1Sy1WQpHjk
4
27
86
@GeriSoc
British Geriatrics Society
1 year
‘Movement is medicine’ @thebodycoach is supporting @JKDhesi @CPOC_News @GSTTnhs to help patients prepare for surgery. These 10-minute routines are tailored for all abilities and particularly suitable for older people. https://t.co/Byu7tBZXFs
3
43
102
@Lyons_LM
Lisa lyons
1 year
Fantastic work by one of our Haematology Clinical Nurse Specialists who led on implementing a yearly checklist to improve the quality of life and outcomes of those living with myeloma. #teamNORTH @KerrieJSweeney @NHSCT https://t.co/OFbK7teYmf
Tweet card summary image
onlinelibrary.wiley.com
Advances in myeloma have resulted in improved prognosis for patients. However complications of the disease and treatment, pose a risk of specific long-term consequences. An audit tool was adapted to...
0
2
11